Establishment of measurement system for KLHL11 antibodies in Japan, and results of measurement in a large number of autoimmune cerebellar ataxia patients | Synapse
March 3, 2026
Establishment of measurement system for KLHL11 antibodies in Japan, and results of measurement in a large number of autoimmune cerebellar ataxia patients
Key Points
KLHL11 antibodies were successfully measured in a significant number of autoimmune cerebellar ataxia patients, providing valuable diagnostic data.
The study measured KLHL11 antibodies in over 100 patients, revealing a potential link between these antibodies and disease pathology.
Establishment of a measurement system with accurate serological assays was conducted to facilitate more robust diagnostics.
Findings may enhance early diagnosis and treatment approaches for autoimmune cerebellar ataxia, suggesting a need for clinical application.